Drugs / M3554
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06641908 | Nov 2024 → Apr 2027 expected | neoplasm | EMD Serono Research & Development Institute, Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M3554 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06641908 ↗ |